Your browser doesn't support javascript.
loading
CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia.
Krishnan, Vinu; Xu, Xian; Kelly, Dakota; Snook, Adam; Waldman, Scott A; Mason, Robert W; Jia, Xinqiao; Rajasekaran, Ayyappan K.
Afiliação
  • Krishnan V; ⊥Nemours Center for Childhood Cancer Research, A. I. duPont Hospital for Children, Wilmington, Delaware 19803, United States.
  • Snook A; #Pharmacology and Experimental Therapeutics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.
  • Waldman SA; #Pharmacology and Experimental Therapeutics, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.
  • Mason RW; ⊥Nemours Center for Childhood Cancer Research, A. I. duPont Hospital for Children, Wilmington, Delaware 19803, United States.
  • Rajasekaran AK; ∇Therapy Architects, LLC, 2700 Silverside Road, Wilmington, Delaware 19810, United States.
Mol Pharm ; 12(6): 2101-11, 2015 Jun 01.
Article em En | MEDLINE | ID: mdl-25898125
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Sistemas de Liberação de Medicamentos / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Sistemas de Liberação de Medicamentos / Antígenos CD19 / Leucemia-Linfoma Linfoblástico de Células Precursoras Idioma: En Ano de publicação: 2015 Tipo de documento: Article